Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Payment Tranche [Axis] Payment Tranche [Axis] Payment Tranche Trading Arrangement: Trading Arrangement [Axis] Title of 12(b) Security Title of 12(b) Security Document Fiscal Year Focus Document Fiscal Year Focus November 2025 Public Offering November 2025 Public Offering [Member] November 2025 Public Offering Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] RSU Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Segment Reporting [Abstract] Common stock: $0.000005 par value— 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 25,832,913 shares issued and 25,805,898 shares outstanding as of June 30, 2026; 24,115,346 shares issued and 24,088,425 shares outstanding as of December 31, 2025 Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Accrued compensation Employee-related Liabilities, Current 2024 Term Loan Two Thousand Twenty Four Loan and Security Agreement [Member] Two thousand twenty four loan and security agreement. Facility-related costs, laboratory equipment, and maintenance Facility Related Costs, Laboratory Equipment, And Maintenance Facility related costs, laboratory equipment, and maintenance. Contract liabilities Loss Contingency Accrual Line of Credit Line of Credit [Member] Restatement Determination Date Restatement Determination Date Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Settlement of restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Class of Warrant or Right [Table] Class of Warrant or Right [Table] ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Change in fair value of warrant liability Fair Value Adjustment of Warrants Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] March 2024 Public Offering March Twenty Twenty Four Public Offering [Member] March twenty twenty four public offering. Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in USD per shares) Common Stock, Par or Stated Value Per Share Assets: Assets, Fair Value Disclosure [Abstract] Intangible assets—net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Unvested, beginning balance (in shares) Unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Basic (in shares) Basic weighted-average common shares (in shares) Weighted Average Number of Shares Outstanding, Basic Issuance of common stock to licensees Stock Issued During Period, Value, Licenses Stock issued during period value licenses. Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Payment Tranche Two Payment Tranche Two [Member] Payment Tranche Two Number of reportable segments Number of Reportable Segments Operating Leases Lessee, Operating Lease, Description [Abstract] Total current liabilities Liabilities, Current 2015 Plan Two Thousand Fifteen Stock Incentive Plan [Member] Two thousand fifteen stock incentive plan. Lease Cost Lease, Cost [Abstract] Entity Address, City or Town Entity Address, City or Town Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Sublease income Sublease Income Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Principal amount Line of Credit Facility, Maximum Borrowing Capacity Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] License License [Member] Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Treasury stock Treasury Stock, Value Accounting Standards Updates New Accounting Pronouncements, Policy [Policy Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Grantee Status [Axis] Grantee Status [Axis] Summary of Significant Research and Development and General and Administrative Expense to CODM Segment Reporting [Table Text Block] Novartis Pharma AG Novartis Pharma A G [Member] Novartis Pharma A.G. Exercise price per share (in USD per shares) Class of Warrant or Right, Exercise Price of Warrants or Rights Marketable securities Increase (Decrease) in Marketable Securities, Restricted Schedule of Future Lease Payments under Non-Cancelable Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Supplemental disclosures of cash flow information: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] (Loss) gain on change in fair value of warrant liability Loss on change in fair value of warrant liability Gain (Loss) on Change in Fair Value of Warrant Liability Gain (loss) on change in fair value of warrant liability. Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Forfeited/canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Issuance of common stock through ATM facility, net of issuance cost Stock Issued During Period, Value Through ATM Facility, Net Of Issuance Cost Stock issued during period value through atm facility, net of issuance cost. Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Unrecognized tax benefits Unrecognized Tax Benefits Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Contract asset Increase (Decrease) in Contract with Customer, Asset Basic net loss per share: Earnings Per Share, Basic [Abstract] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two STOCKHOLDERS' EQUITY Equity [Text Block] Security Exchange Name Security Exchange Name Warrants expire year Debt Instrument, Term Investor Investor [Member] Effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Proceeds from issuance of common stock to collaboration partners and licensees Proceeds from Noncontrolling Interests Granted (in USD per shares) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Agriculture Industry Collaboration Partner Agriculture Industry Collaboration Partner [Member] Agriculture Industry Collaboration Partner Subsidiary or Equity Method Investee [Line Items] Subsidiary or Equity Method Investee [Line Items] Liabilities Liabilities, Fair Value Disclosure Entity Shell Company Entity Shell Company Maximum shares allowed to be issued under ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Lease liabilities Operating Lease, Liability, Current Segment Reporting Segment Reporting, Policy [Policy Text Block] EARNINGS PER SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Net loss per share Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] General and administrative expense General and Administrative Expense [Abstract] Number of shares available for issuance (in shares) Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance Share based compensation arrangement by share based payment award number of shares available for issuance. Total liabilities Liabilities Trading Symbol Trading Symbol Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Company Selected Measure Name Company Selected Measure Name One-Half Warrants One-Half Warrants [Member] One-Half Warrants Sale of Stock Sale of Stock [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] FAIR VALUE MEASUREMENTS Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Investment in iECURE Investment In iECURE [Member] Investment in iECURE member. Diluted net loss per share: Earnings Per Share, Diluted [Abstract] Credit Facility Credit Facility [Domain] Asset Class Asset Class [Domain] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Cash flows used in operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Diluted (in shares) Diluted weighted-average common shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average fair value per option Measurement Input, Weighted-Average Fair Value Per Option [Member] Measurement input, weighted-average fair value per option. Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Warrants Derivatives, Policy [Policy Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Dilutive impact of share-based awards (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Summary of Financial Assets Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Development and License Development and License [Member] Development and License Operating cash flows used for operating leases Operating Lease, Payments Award Timing Predetermined Award Timing Predetermined [Flag] Treasury Stock Treasury Stock, Common [Member] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Level 1 Fair Value, Inputs, Level 1 [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Number of additional shares available for issuance (in shares) Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Available For Issuance Share based compensation arrangement by share based payment award number of additional shares available for issuance. Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Grantee Status [Domain] Grantee Status [Domain] Total lease payments Lessee, Operating Lease, Liability, to be Paid Issuance of common stock through ATM facility, net of issuance cost (in shares) Stock Issued During Period Through ATM Facility, Net Of Issuance Cost, Shares Stock issued during period through atm facility, net of issuance cost shares. Unvested, beginning balance (in USD per shares) Unvested, ending balance (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Lease liabilities Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in USD per shares) Preferred Stock, Par or Stated Value Per Share Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Plan Name Plan Name [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Scenario Scenario [Domain] Weighted-average exercise price outstanding at beginning balance (in USD per shares) Weighted-average exercise price outstanding at ending balance (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Reconciliation of cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Right-of-use assets—net Operating Lease, Right-of-Use Asset Schedule of Basic and Diluted Net (Loss) Income Per Share Attributable to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Purchases of intangible assets Payments To Purchase Intangible Assets Payments To Purchase Intangible Assets Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] iECURE I E C U R E [Member] iECURE member. Debt Instrument, Name Debt Instrument, Name [Domain] SEGMENT REPORTING Segment Reporting [Text Block] Warrant liability Warrant Liability Noncurrent Warrant liability noncurrent. Borrowings Long-Term Line of Credit Expiration Date Trading Arrangement Expiration Date Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Income Statement Location Location, Statement of Income, Balance [Axis] Restricted cash Restricted Cash and Cash Equivalent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Money market funds Cash and Cash Equivalents, Fair Value Disclosure Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Final payment fee Financial Liabilities Fair Value Disclosure Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Security, Excluded EPS Calculation [Table] Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Imugene Marketable Securities Imugene [Member] Imugene. Summary of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Amended Plan Amended Plan [Member] Amended Plan member. Exercise Price Award Exercise Price Cash flows used in investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Segment Reporting [Line Items] Segment Reporting [Line Items] Issuance of common stock to licensees (in shares) Stock Issued During Period, Licenses, Shares Stock issued during period licenses shares. Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Percentage of premium over the volume-weighted-average-price of the company’s common stock (as a percent) Percentage Of Premium Over Volume Weighted Average Price Of Company's Common Stock Percentage of premium over the volume-weighted-average-price of the company’s common stock. DEBT Debt Disclosure [Text Block] Scenario Scenario [Axis] Fair Value Warrant Liability Fair Value Warrant Liability [Roll Forward] Fair Value Warrant Liability Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] (Loss) gain from changes in fair value included in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Net proceeds from sale of stock Sale of Stock, Consideration Received on Transaction Adoption Date Trading Arrangement Adoption Date Counterparty Name Counterparty Name [Domain] Interest rate during period (as a percent) Debt Instrument, Interest Rate, Stated Percentage Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Proceeds from employee stock purchase plan Proceeds From Employee Stock Purchase Plan Proceeds from employee stock purchase plan Amortization of discount on note receivable Amortization Of Discount On Note Receivable Amortization of discount on note receivable. Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Laboratory supplies and services Laboratory Supplies And Services Laboratory supplies and services. Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total operating lease liabilities Operating Lease, Liability Offering expenses Payments of Stock Issuance Costs Insider Trading Policies and Procedures [Line Items] Options outstanding (in shares) Outstanding option shares, beginning balance (in shares) Outstanding option shares, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of trading days prior to agreement to determine price per share Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Forfeited/canceled (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Contract with customer, liability, revenue recognized as transaction price Contract With Customer, Liability, Revenue Recognized As Transaction Price Contract With Customer, Liability, Revenue Recognized As Transaction Price Estimated dividend yield Measurement Input, Expected Dividend Rate [Member] Number of operating segments Number of Operating Segments Antidilutive common share equivalents (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Restricted Stock Units Restricted Stock Units (RSUs) [Member] Platform development and early-stage research expenses: Platform Development And Early-Stage Research Expenses [Abstract] Platform development and early-stage research expenses. Entity Central Index Key Entity Central Index Key Additional paid-in capital Additional Paid in Capital, Common Stock All Adjustments to Compensation All Adjustments to Compensation [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Issuance of common stock under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Operating expenses Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Contract with customer, liability, revenue recognized upon issuance of shares Contract With Customer, Liability, Revenue Recognized Upon Issuance of Shares Contract with Customer, Liability, Revenue Recognized Upon Issuance of Shares Outstanding Option Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Basis point added to the prime rate (as percent) Debt Instrument, Basis Spread on Variable Rate City Area Code City Area Code All Individuals All Individuals [Member] SUBSEQUENT EVENTS Subsequent Events [Text Block] Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Name Forgone Recovery, Individual Name Research and development Research and Development [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Weighted-average period for recognition of compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Number of shares available to be issued (in shares) Common Stock, Capital Shares Reserved for Future Issuance PBGENE-DMD external development costs PBGENE - Duchenne Muscular Dystrophy Program [Member] PBGENE-Duchenne Muscular Dystrophy Program. Interest expense Interest Expense, Nonoperating Schedule of Share-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan PEO PEO [Member] Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Income tax disclosure. WARRANTS Warrants [Text Block] Warrants. Prepaid expenses Increase (Decrease) in Prepaid Expense Accrued research and development expenses Accrued Research And Development Expenses Accrued research and development expenses. Share-based compensation expense Share based compensation expense Share-Based Payment Arrangement, Expense Marketable securities Marketable Securities, Current Other noncurrent liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Granted (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Revenue recognized Contract with Customer, Liability, Revenue Recognized Loss on changes in other fair value adjustments Gain (loss) on changes in fair value of ordinary shares Equity Securities, FV-NI, Gain (Loss) Accumulated Deficit Retained Earnings [Member] Lease liabilities Operating Lease, Liability, Noncurrent Total operating expenses Operating Expenses Revolving Credit Facility Revolving Credit Facility [Member] Shares outstanding percentage (as percent) Warrants or Rights Outstanding, Ownership Of Common Stock Outstanding, Percentage, Condition For Company Repurchase Warrants or Rights Outstanding, Ownership Of Common Stock Outstanding, Percentage, Condition For Company Repurchase Forfeited (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Estimated Fair Value of Warrants Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Diluted (in USD per shares) Diluted net loss per share (in USD per shares) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Proceeds from issuance of common stock through ATM facility, net of issuance cost Proceeds from Issuance of Common Stock through ATM Facility, Net of Issuance Cost Proceeds from issuance of common stock through ATM facility, net of issuance cost Total Shareholder Return Amount Total Shareholder Return Amount Liabilities: Liabilities, Fair Value Disclosure [Abstract] Licensing fees and other research and development costs Licensing Fees And Other Research And Development, Costs Licensing fees and other research and development costs. Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Research and development Total research and development expenses Research and Development Expense Weighted-average expected stock price volatility Measurement Input, Share Price [Member] March 2024 Public Offering March 2024 Public Offering [Member] March 2024 Public Offering Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash flows provided by financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Property, equipment, and software—net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Financial Instruments [Domain] Financial Instruments [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Issuance of common stock from pre-funded warrants (in shares) Stock Issued During Period, Shares, Warrant Exercise Stock Issued During Period, Shares, Warrant Exercise Prepaid expenses Prepaid Expense, Current Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Segment Reporting [Table] Segment Reporting [Table] Remaining shares available to be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Sale of Stock Sale of Stock [Axis] Escrow account cash balance Escrow Deposit Schedule of Components of Lease Expense Lease, Cost [Table Text Block] Other current assets Other Assets, Current Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Other (expense) income: Other Nonoperating Income (Expense) [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Operating loss Operating loss Operating Income (Loss) Research and License Research and License [Member] Research and License Current Fiscal Year End Date Current Fiscal Year End Date Beginning balance Ending balance Warrants and Rights Outstanding Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount External development costs (credits) External Development Costs (Credits) External development costs. Unaudited Interim Financial Information Comparability of Prior Year Financial Data, Policy [Policy Text Block] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Summary of Warrant Liability Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Investment in iECURE Equity Securities [Member] Summary of Activity of Option Plans Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Other Information Cash Flow, Operating Activities, Lessee [Abstract] Non-cash interest expense Amortization of Debt Discount (Premium) Total number of shares issued under 2019 ESPP (in shares) Numberof Shares Issued Under Employee Stock Purchase Plans Number of shares issued under employee stock purchase plans. Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock (as a percent) Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Increase In Shares Authorized As Percentage Of Outstanding Shares Of Common Stock Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock. Loan payable Loans Payable Other operating expenses and all other costs Other Cost and Expense, Operating Equity Component [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Weighted-average shares of common stock outstanding Earnings Per Share, Diluted, Other Disclosure [Abstract] Operating Segment Operating Segment [Member] Operating Segment Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Unamortized revolving line debt discount balance Debt Instrument, Unamortized Discount Termination Date Trading Arrangement Termination Date Income Tax Disclosure [Table] Effective Income Tax Rate Reconciliation [Table] (Loss) income from operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Subsequent Events [Abstract] Subsequent Events [Abstract] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other current liabilities Other Liabilities, Current Other assets Other Assets, Noncurrent Document Type Document Type Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Gain (loss) on disposal of assets Gain (Loss) on Disposition of Assets Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Loan and Security Agreement Loan and Security Agreement [Member] Loan and Security Agreement Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Warrants assumptions Warrants and Rights Outstanding, Measurement Input (Loss) gain from equity method investment Gain from equity method investment Income (Loss) from Equity Method Investments Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Issuance of warrants Warrants and Rights Issued Warrants and Rights Issued Counterparty Name Counterparty Name [Axis] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Schedule of Assets and Liabilities Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] All Award Types Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Warrants outstanding (in shares) Class of Warrant or Right, Outstanding 2026 (remainder of year) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Level 3 Fair Value, Inputs, Level 3 [Member] Other liabilities and other current liabilities Increase Decrease In Accrued Other Expenses And Other Current Liabilities Increase decrease in accrued other expenses and other current liabilities. Pre Funded Warrants Pre Funded Warrants [Member] Pre Funded Warrants PEO Name PEO Name Restricted cash Restricted Cash Collaborative arrangement, upfront payments and liabilities Contract with Customer, Liability 2019 ESPP Two Thousand Nineteen Employee Stock Purchase Plan [Member] Two thousand nineteen employee stock purchase plan. Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Exercised (in USD per shares) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash, cash equivalents, and restricted cash — beginning of period Cash, cash equivalents, and restricted cash — end of period Total of cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Collaboration and License Agreements [Line items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Accounts payable Increase (Decrease) in Accounts Payable Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Consulting and professional services Consulting And Professional Services Consulting and professional services. Employee Share-Based Payment Arrangement, Employee [Member] Debt Instrument Debt Instrument [Axis] Share-based compensation Share-Based Payment Arrangement, Noncash Expense Total Lease Cost Lease, Cost Purchase of common stock through payroll deductions expressed in percentage of fair market value (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Warrants exercised (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Employee Stock Employee Stock [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in USD per shares) Basic net loss per share (in USD per shares) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Weighted-average risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Total current assets Assets, Current Insider Trading Arrangements [Line Items] 2019 Plan Two Thousand Nineteen Incentive Award Plan [Member] Two thousand nineteen incentive award plan. Award Type Award Type [Axis] Short-term lease cost Short-Term Lease, Cost Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Investments and marketable securities Equity Securities, FV-NI TG License TG License [Member] TG license. Employee-related costs (including share-based compensation) Employee Related Costs Research And Development Including Share-Based Compensation Employee related costs research and development including share-based compensation. Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Additional milestone Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Contract liabilities Business Combination, Contingent Consideration, Liability Operating lease cost Operating Lease, Cost Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Cover [Abstract] Cover [Abstract] Intangible asset additions included in accounts payable and accrued expenses and other current liabilities Noncash or Part Noncash Acquisition, Intangible Assets Acquired Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Equity Awards Adjustments Equity Awards Adjustments [Member] COLLABORATION AND LICENSE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Variable lease cost Variable Lease, Cost Interest income Interest Income, Other Employee Stock Option Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Asset Class Asset Class [Axis] Plan Name Plan Name [Axis] Proceeds from sale of equipment Proceeds from Sale of Machinery and Equipment Tabular List, Table Tabular List [Table Text Block] Investment in equity securities Equity Securities, FV-NI, Noncurrent Inducement Award Plan Inducement Award Plan [Member] Inducement award plan member. Schedule of Share-Based Compensation Expense by Line Item Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Total other expense Other Nonoperating Income (Expense) Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period (Gain) loss on disposal of assets Gain (Loss) on Disposition of Assets for Financial Service Operations General and administrative Total general and administrative expenses General and Administrative Expense Sale of stock, price per share (in USD per shares) Sale of Stock, Price Per Share PBGENE-HBV external development costs PBGENE - Hepatitis B Virus [Member] Potential treatment of chronic hepatitis B virus. Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock: $0.0001 par value— 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Adjustment to Compensation: Adjustment to Compensation [Axis] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Purchases of property, equipment and software Payments to Acquire Productive Assets Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] CMOs and outsourced research and development CMOs And Outsourced Research And Development CMOs and outsourced research and development. Credit Facility Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Assets Assets, Fair Value Disclosure Name Measure Name INCOME TAXES Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Payment Tranche [Domain] Payment Tranche [Domain] Payment Tranche [Domain] Direct research and development expenses by product candidate: Direct Research And Development Expenses By Product Candidate [Abstract] Direct Research And Development Expenses By Product Candidate Additional Paid-In Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Discovery and Development Discovery and Development [Member] Discovery and Development Shares available for exchange (in shares) Collaborative Arrangement, Shares Available For Exchange Collaborative Arrangement, Shares Available For Exchange Subsidiary or Equity Method Investee, Sale of Stock [Table] Subsidiary or Equity Method Investee, Sale of Stock [Table] Other assets and other current assets Increase Decrease In Other Assets And Other Current Assets Increase decrease in other assets and other current assets. Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Expected term (in years) Measurement Input, Expected Term [Member] Company Selected Measure Amount Company Selected Measure Amount RSU outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Employee-related costs (including share-based compensation) Employee Related Costs, General And Administrative Expense Employee Related Costs, General And Administrative Expense Entity Address, Address Line Two Entity Address, Address Line Two Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Current assets: Assets, Current [Abstract] Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Warrant Liability Derivative Liability Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Vested (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Award Timing Method Award Timing Method [Text Block] Net decrease in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forecast Forecast [Member] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Net (loss) income Net loss Net loss Net Income (Loss) Attributable to Parent Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Payment Tranche One Payment Tranche One [Member] Payment Tranche One Loss on changes in other fair value adjustments Fair Value, Option, Changes in Fair Value, Gain (Loss) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]